Seegene Inc.

Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1

Introduces Novaplex™ MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Clade IIAdheres to the WHO issued target product profiles and provides accurate detection of viral strainsOffers healthcare professionals with a critical tool in their research on the global spread of mpox by supporting international effortsand follow linkedin.com/company/seegene-inc

Photo - https://mma.prnewswire.com/media/2499983/Photo__Seegene_Expands_mpox_RUO_Product_Lineups_with_Enhanced_Detection_Assays_for_Clade_1.jpg
Logo - https://mma.prnewswire.com/media/1357790/Seegene_logo_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/seegene-expands-mpox-ruo-product-lineups-with-enhanced-detection-assays-for-clade-1-302242213.html